Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Barbara Walch-Rückheim

5PUBLICATIONS

1CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jan 24, 2026

Th17 cells favor migration and invasiveness of cervical cancer cells under hypoxia in an IGF2BP2-dependent manner.

Selina Gies, Maike Pohlers, Tanja Tänzer

|Mar 14, 2025

PD-L1<sup>+</sup> CD49f<sup>+</sup> CD133<sup>+</sup> Circulating tumor cells predict outcome of patients with vulvar or cervical cancer after radio- and chemoradiotherapy.

Selina Gies, Patrick Melchior, Istvan Molnar

|Oct 30, 2023

Th17 cells target the metabolic miR-142-5p-succinate dehydrogenase subunit C/D (SDHC/SDHD) axis, promoting invasiveness and progression of cervical cancers.

Maike Pohlers, Selina Gies, Tanja Taenzer

|Oct 03, 2023

Immune landscape of vulvar cancer patients treated with surgery and adjuvant radiotherapy revealed restricted T cell functionality and increased IL-17 expression associated with cancer relapse.

Selina Gies, Patrick Melchior, Russalina Stroeder

|Sep 01, 2021

Chemoradiotherapy-induced increase in Th17 cell frequency in cervical cancer patients is associated with therapy resistance and early relapse.

Laura Theobald, Russalina Stroeder, Patrick Melchior

Pageof 1

Frequent Collaborators

1 joint publications

David Schub

Frequent Collaborators

1 joint publications

David Schub

Top Related Videos

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Published on : Apr 02, 2020

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

In Vitro Differentiation of Naive CD4<sup>+</sup> T Cells into Pathogenic Th17 Cells in Mouse

In Vitro Differentiation of Naive CD4<sup>+</sup> T Cells into Pathogenic Th17 Cells in Mouse

Published on : Oct 25, 2024

See more related videos

Top Related Videos

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Published on : Apr 02, 2020

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

In Vitro Differentiation of Naive CD4<sup>+</sup> T Cells into Pathogenic Th17 Cells in Mouse

In Vitro Differentiation of Naive CD4<sup>+</sup> T Cells into Pathogenic Th17 Cells in Mouse

Published on : Oct 25, 2024

See more related videos